Picture of Akari Therapeutics logo

AKTX Akari Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

On October 22 Appointed Kameel Farag As Interim CFO - SEC Filing

Oct 24 (Reuters) - Akari Therapeutics PLC AKTX.O:

AKARI THERAPEUTICS PLC - ON OCTOBER 22 APPOINTED KAMEEL FARAG AS INTERIM CFO - SEC FILING

Source text: [ID:n0001493152-25-019112]

Further company coverage: AKTX.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Akari Therapeutics

See all news